CoreFirst Bank & Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$101K Hold
1,160
0.05% 160
2025
Q4
$111K Sell
1,160
-100
-8% -$9.71K 0.06% 150
2025
Q3
$120K Sell
1,260
-192
-13% -$17.6K 0.06% 150
2025
Q2
$127K Buy
+1,452
New +$123K 0.07% 143
2025
Q1
Sell
-1,460
Closed -$117K 256
2024
Q4
$117K Sell
1,460
-822
-36% -$71.2K 0.07% 141
2024
Q3
$205K Buy
+2,282
New +$192K 0.12% 120
2024
Q2
Sell
-2,278
Closed -$199K 267
2024
Q1
$199K Sell
2,278
-173
-7% -$14.8K 0.12% 125
2023
Q4
$202K Sell
2,451
-471
-16% -$35.9K 0.13% 120
2023
Q3
$229K Sell
2,922
-101
-3% -$8.46K 0.16% 112
2023
Q2
$266K Hold
3,023
0.19% 106
2023
Q1
$244K Sell
3,023
-88
-3% -$7.17K 0.18% 116
2022
Q4
$242K Sell
3,111
-38
-1% -$3.08K 0.18% 123
2022
Q3
$254K Buy
3,149
+126
+4% +$11.3K 0.22% 103
2022
Q2
$272K Buy
3,023
+100
+3% +$10.1K 0.21% 102
2022
Q1
$324K Hold
2,923
0.22% 101
2021
Q4
$302K Hold
2,923
0.2% 107
2021
Q3
$367K Hold
2,923
0.25% 96
2021
Q2
$362K Hold
2,923
0.25% 94
2021
Q1
$345K Hold
2,923
0.24% 94
2020
Q4
$342K Buy
+2,923
New +$322K 0.25% 86

Other funds holding MDT

CoreFirst Bank & Trust's MDT Position: Q1 2026 in Review

CoreFirst Bank & Trust held its Medtronic (MDT) position steady in Q1 2026 at 1,160 shares worth $101K. The position accounts for 0.05% of the portfolio, ranked #160.

CoreFirst Bank & Trust first reported a position in MDT in Q4 2020 and has held it in 20 quarters since. The position peaked at $367K in Q3 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • CoreFirst Bank & Trust held 1,160 shares of Medtronic worth $101K as of Q1 2026.
  • CoreFirst Bank & Trust left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.05% of CoreFirst Bank & Trust's portfolio in Q1 2026, its #160 holding.
  • CoreFirst Bank & Trust first reported a position in Medtronic in Q4 2020 and has held it in 20 quarters since.
  • CoreFirst Bank & Trust's Medtronic position peaked at $367K in Q3 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on CoreFirst Bank & Trust's 13F filing for Q1 2026, filed 3 Jun 2026.